88% of EYLEA HD patients had a last assigned dosing interval of ≥12 weeks at week 156, while sustaining visual…
The grant, which is awarded to companies developing significantly impactful technologies with the potential to change clinical practice, will support…
The digital twin AI platform helps patients safely eliminate blood pressure medications and sustain normal blood pressure MOUNTAIN VIEW, Calif.,…
KELOWNA, BC / ACCESSWIRE / October 8, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX) & (NASDAQ:LEXXW) (the "Company" or "Lexaria"), a…
Hello Heart selects Amwell platform to extend its reach across patient populationsBOSTON and MENLO PARK, Calif., Oct. 08, 2024 (GLOBE…
Patients identified with reduced ejection fraction using Eko Health AI were twice as likely to experience heart attacks, heart failure,…
This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix Pharmaceuticals Holding…
BENTONVILLE, Ark., Sept. 30, 2024 /PRNewswire/ -- HeartX, powered by HealthTech Arkansas and MedAxiom — along with numerous leading cardiology practices…
– On track to announce topline data in Q1 2025 – – Virtual KOL event scheduled on October 30th to…
Learnings from the Field: Managing PSVT and Studying AFib-RVR in the Community Setting Hosted 10 am ET, Tuesday, October 8,…